Wed, February 23, 2011
Tue, February 22, 2011
Mon, February 21, 2011
Fri, February 18, 2011
[ Fri, Feb 18th 2011 ]: Market Wire
RS Completes Equity Offering
Thu, February 17, 2011
Wed, February 16, 2011
[ Wed, Feb 16th 2011 ]: Market Wire
2010 Fourth Quarter Results
Tue, February 15, 2011
Mon, February 14, 2011

Fibrocell Science, Inc. to Present at The Wall Street Analyst Forum 22nd Annual Analyst Conference


  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. nalyst-forum-22nd-annual-analyst-conference.html
  Print publication without navigation Published in Stocks and Investing on by Market Wire


EXTON, Pa.--([ BUSINESS WIRE ])--Fibrocell Science, Inc. (OTCBB: FCSC), a biotechnology company focused on the development of autologous (personalized) cell therapies for aesthetic, medical and scientific applications, announced today that David Pernock, the Companya™s Chairman and CEO, will be presenting at The Wall Street Analyst Forum 22nd Annual Analyst Conference to be held on Tuesday, March 1, at TheUniversity Club (1 West 54th Street) in NYC.

Fibrocella™s presentation is scheduled for 12:05 p.m. Eastern Time.

The audio portion of the presentation will be webcast live, and a replay will be available on the Investors section of the Company's website at [ www.fibrocellscience.com ].

About Fibrocell Science, Inc.

Fibrocell Science, Inc. (OTCBB: FCSC) is a biotechnology company focused on the development of autologous (personalized) cell therapies for aesthetic, medical and scientific applications. Fibrocell Science is committed to advancing the scientific, medical and commercial potential of autologous skin and tissue, as well its innovative cellular processing technology and manufacturing excellence. For additional information, please visit [ www.fibrocellscience.com ].


Publication Contributing Sources

Publication Sponsors
[ Last Sunday ] - Oceanside Rental Gear